1. Home
  2. CRIS vs ACXP Comparison

CRIS vs ACXP Comparison

Compare CRIS & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • ACXP
  • Stock Information
  • Founded
  • CRIS 2000
  • ACXP 2017
  • Country
  • CRIS United States
  • ACXP United States
  • Employees
  • CRIS N/A
  • ACXP N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRIS Health Care
  • ACXP Health Care
  • Exchange
  • CRIS Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • CRIS 32.8M
  • ACXP 31.4M
  • IPO Year
  • CRIS 2000
  • ACXP 2021
  • Fundamental
  • Price
  • CRIS $3.21
  • ACXP $0.76
  • Analyst Decision
  • CRIS Strong Buy
  • ACXP Strong Buy
  • Analyst Count
  • CRIS 3
  • ACXP 1
  • Target Price
  • CRIS $23.00
  • ACXP $12.00
  • AVG Volume (30 Days)
  • CRIS 35.0K
  • ACXP 273.8K
  • Earning Date
  • CRIS 02-18-2025
  • ACXP 03-14-2025
  • Dividend Yield
  • CRIS N/A
  • ACXP N/A
  • EPS Growth
  • CRIS N/A
  • ACXP N/A
  • EPS
  • CRIS N/A
  • ACXP N/A
  • Revenue
  • CRIS $10,259,000.00
  • ACXP N/A
  • Revenue This Year
  • CRIS N/A
  • ACXP N/A
  • Revenue Next Year
  • CRIS N/A
  • ACXP N/A
  • P/E Ratio
  • CRIS N/A
  • ACXP N/A
  • Revenue Growth
  • CRIS 0.44
  • ACXP N/A
  • 52 Week Low
  • CRIS $2.86
  • ACXP $0.68
  • 52 Week High
  • CRIS $17.49
  • ACXP $3.35
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 44.00
  • ACXP 44.22
  • Support Level
  • CRIS $3.05
  • ACXP $0.75
  • Resistance Level
  • CRIS $3.55
  • ACXP $0.82
  • Average True Range (ATR)
  • CRIS 0.23
  • ACXP 0.05
  • MACD
  • CRIS 0.01
  • ACXP 0.01
  • Stochastic Oscillator
  • CRIS 26.67
  • ACXP 29.23

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Share on Social Networks: